Qiming Wang

6PUBLICATIONS
64CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersAvionics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 26, 2024
Vebreltinib for Advanced Non-Small Cell Lung Cancer Harboring c-Met Exon 14 Skipping Mutation: A Multicenter, Single-Arm, Phase II KUNPENG Study.

Jin-Ji Yang, Yan Zhang, Lin Wu

|May 30, 2024
EHMT2-mediated transcriptional reprogramming drives neuroendocrine transformation in non-small cell lung cancer.

Cheng Yang, Shuxiang Ma, Jie Zhang

|May 06, 2024
Capecitabine or Capecitabine Plus Oxaliplatin Versus Fluorouracil Plus Cisplatin in Definitive Concurrent Chemoradiotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma (CRTCOESC): A Multicenter, Randomized, Open-Label, Phase 3 Trial.

Ruinuo Jia, Tanyou Shan, Anping Zheng

|Jul 14, 2023
HLA-I Evolutionary Divergence Confers Response to PD-1 Blockade plus Chemotherapy in Untreated Advanced Non-Small Cell Lung Cancer.

Tao Jiang, Qiqi Jin, Jiahao Wang

|Oct 07, 2022
Toripalimab Plus Chemotherapy for Patients With Treatment-Naive Advanced Non-Small-Cell Lung Cancer: A Multicenter Randomized Phase III Trial (CHOICE-01).

Zhijie Wang, Lin Wu, Baolan Li

|May 17, 2022
AENEAS: A Randomized Phase III Trial of Aumolertinib Versus Gefitinib as First-Line Therapy for Locally Advanced or MetastaticNon-Small-Cell Lung Cancer With <i>EGFR</i> Exon 19 Deletion or L858R Mutations.

Shun Lu, Xiaorong Dong, Hong Jian

Pageof 1

Frequent Collaborators

3 joint publications

Ying Cheng

2 joint publications

Lin Wu

2 joint publications

Zhuang Yu

1 joint publications

Jin-Ji Yang